CAS: 1392116-14-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JD 5037 REF: IN-DA01EONNCAS: 1392116-14-1 | 98% | To inquire | Fri 29 Nov 24 |
 | JD-5037 REF: TM-T4453CAS: 1392116-14-1 | 98.14% - 98.87% | 43.00 €~538.00 € | Thu 05 Dec 24 |
 | JD 5037 REF: 3D-FJ166461CAS: 1392116-14-1 | Min. 95% | To inquire | Thu 09 Jan 25 |
Ref: IN-DA01EONN
| 5mg | 157.00 € | ||
| 25mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 29 Nov 2024
JD-5037
CAS:1392116-14-1
JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.
Formula:
C27H27Cl2N5O3S
Purity:
98.14% - 98.87%
Color and Shape:
Solid
Molecular weight:
572.51
Ref: TM-T4453
| 1mg | 43.00 € | ||
| 2mg | 57.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 139.00 € | ||
| 25mg | 241.00 € | ||
| 50mg | 362.00 € | ||
| 100mg | 538.00 € | ||
| 1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
JD 5037
CAS:1392116-14-1
JD 5037 is a monoclonal antibody that inhibits the binding of endocannabinoids to their receptors. …
Formula:
C27H27C12N5O3S
Purity:
Min. 95%
Molecular weight:
645.73 g/mol
Ref: 3D-FJ166461
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
